摘要
目的:研究甘肃地区汉族妇女XRCC1 rs25487、CCNH rs2234942基因多态性与乳腺癌及乳腺良性肿瘤发病的相关性。方法:选取经病理组织学确诊的乳腺癌、乳腺良性肿瘤各101例,匹配相同数量健康人作对照。使用聚合酶链式反应-限制性片段长度多态分析技术(PCR-RFLP)对XRCC1、CCNH进行基因型分析,通过Logistic回归分析不同基因型和临床病理特征与乳腺癌发病2的风险性关系,通过检验比较两种基因位点不同基因型的初潮年龄、发病年龄与乳腺癌和乳腺良性肿瘤的相关性。结果:Logistic回归分析发现XRCC1 rs25487位点GG基因型携带者的妇女罹患乳腺癌的危险性增加(P=0.001,OR=6.39,95%CI:2.18^+-18.65);临床病理免疫组化分析显示,XRCC1基因rs25487位点携带AA/AG基因型者,在PR与PR乳腺癌组织间的分布差异有显著+-2性(P=0.04,OR=0.29);携带AG/GG基因型者,在Her-2与Her-2乳腺癌组织间的分布差异有显著性(P=0.008,OR=0.45)。检验显示,乳腺癌和乳腺良性肿瘤患者XRCC1 rs25487位点GG/AG基因型携带者的初潮年龄差异有显著性(P=0.001、0.043);乳腺癌和乳腺良性肿瘤患者CCNH rs2234942位点GG基因型携带者的初潮年龄差异有显著性(P=0.049);乳腺癌和乳腺良性肿瘤患者XRCC1rs25487和CCNH rs2234942位点GG基因型携带者,发病年龄差异有显著性(P=0.019、0.048)。结论:XRCC1 rs25487 GG基因型将会+增加乳腺癌的发病风险,XRCC1 rs25487位点携带AA/AG基因型者,在PR时乳腺癌的发病风险下降;携带AG/GG基因型者,在+Her-2时可能降低乳腺癌的发病风险。
To study the association between XRCC1 rs25487 and CCNH rs2234942 polymorphism with the susceptibility to breast cancer and benign breast tumor in Han women in Gansu area. METHODS:Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay was used for the polymorphism of XRCC1,CCNH in 101 cases of breast cancer,101 benign breast tumors and 101 disease-free controls collected in Gansu. Logistic regression analysis was used for comparing the genotypes or clinical pathological characteristics with the risk of breast cancer. Chi-square test was used to compare menarche age and disease onset age with the risk of breast cancer or benign tumor. RESULTS:Logistic regression analysis showed that XRCC1 rs25487,GG genotype increased the risk of breast cancer (P=0.001,OR=6.39,95%CI:2.18-18.65). Regarding the clinicopathological immunohistochemical characteristics,the distribution of AA/AG genotype was significantly different+ -between PR and PR at XRCC1 rs25487(P=0.04,OR=0.29),while the distribution of AG/GG genotype was significantly+ -different in Her-2 cases and Her-2 (P=0.008,OR=0.45). Chi-square test found that the menarche age of GG/AG genotype in XRCC1 rs25487 and GG genotype in CCNH rs2234942 was significantly different in breast cancer and benign tumor (P=0.001,0.043,0.049). The disease onset age of GG genotype in both XRCC1 rs25487 and CCNH rs2234942 was significantly different in breast cancer and benign tumor(P=0.019,0.048). CONCLUSION:GG genotype in+XRCC1 rs25487 increased the risk of breast cancer. AA/AG genotype in XRCC1 rs25487 with PR and AG/GG genotype in+CCNH rs2234942 with Her-2 reduced the risk of breast cancer.
出处
《癌变.畸变.突变》
CAS
CSCD
2014年第4期292-297,共6页
Carcinogenesis,Teratogenesis & Mutagenesis
基金
甘肃省科技厅支撑项目(1011FKCA089)
甘肃省卫生行业计划项目(GSWST2010-08)